US Venture Partners X LP's Form 4 filing
eFFECTOR Therapeutics, Inc.EFTR · filed Nov 12, 2021
- Accession no.
- 0001062993-21-010758
- Filed
- Nov 12, 2021, 5:52 PM ET
- Trade date
- Nov 9-12, 2021
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 8 non-derivative transactions. Open-market sales total $917.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| US Venture Partners X LPCIK 0001440514 | 10% Owner |
| Usvp X Affiliates LPCIK 0001453359 | 10% Owner |
| Tansey Casey MCIK 0001474322 | 10% Owner |
| Presidio Management Group X LLCCIK 0001602744 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 9, 2021 | Common Stock | SSaleDisposed | −27,892 | $11.00F1 | −$306,923.57 | 4,644,736 | Indirect | |
| Nov 9, 2021 | Common Stock | SSaleDisposed | −893 | $11.00F1 | −$9,826.57 | 148,593 | Indirect | |
| Nov 10, 2021 | Common Stock | SSaleDisposed | −32,946 | $10.44F1 | −$343,824.46 | 4,611,790 | Indirect | |
| Nov 10, 2021 | Common Stock | SSaleDisposed | −1,054 | $10.44F1 | −$10,999.54 | 147,539 | Indirect | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −11,644 | $10.37F1 | −$120,724.99 | 4,600,146 | Indirect | |
| Nov 11, 2021 | Common Stock | SSaleDisposed | −373 | $10.37F1 | −$3,867.26 | 147,166 | Indirect | |
| Nov 12, 2021 | Common Stock | SSaleDisposed | −11,628 | $10.07F1 | −$117,093.96 | 4,588,518 | Indirect | |
| Nov 12, 2021 | Common Stock | SSaleDisposed | −372 | $10.07F1 | −$3,746.04 | 146,794 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.57 to $11.82, inclusive for sales on 11/9/21; prices ranging from $10.22 to $10.72, inclusive for sales on 11/10/21; prices ranging from $10.16 to $10.56, inclusive for sales on 11/11/21; and prices ranging from $10.00 to $10.22, inclusive for sales on 11/12/21. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4
Referenced by the price of 8 transactions in Table I.